Results 1 to 10 of about 172,093 (166)
JAMAImportanceInterstitial lung disease (ILD) consists of a group of pulmonary disorders characterized by inflammation and/or fibrosis of the lung parenchyma associated with progressive dyspnea that frequently results in end-stage respiratory failure. In the US, ILD affects approximately 650 000 people and causes approximately 25 000 to 30 000 deaths per ...
Kanchustambham V, Sankari A.
europepmc +4 more sources
Pulmonology, 2020 Introduction Chronic hypersensitivity pneumonitis (CHP) is an interstitial lung disease with limited treatment response and bad prognosis. Sometimes it is indistinguishable from idiopathic pulmonary fibrosis (IPF) becoming one of the main differential ...
Maria Laura Alberti +6 more
doaj +3 more sources
Lung transplantation for interstitial lung disease [PDF]
European Respiratory Review, 2021 Lung transplantation (LTx) can be a life-extending treatment option for patients with advanced and/or progressive fibrotic interstitial lung disease (ILD), especially idiopathic pulmonary fibrosis (IPF), fibrotic hypersensitivity pneumonitis, sarcoidosis and connective tissue disease-associated ILD.
Siddhartha G. Kapnadak, Ganesh Raghu
openaire +3 more sources
BJGP Open, 2021 Background: Long-term nitrofurantoin (NF) treatment can result in pulmonary and hepatic injury. Current guidelines do not outline the type or frequency of monitoring required for detection of these injuries.
Toby Peter Speirs +16 more
doaj +1 more source
A multidisciplinary approach to the diagnosis of antisynthetase syndrome
Frontiers in Medicine, 2022 Antisynthetase syndrome is a subtype of idiopathic inflammatory myopathy, strongly associated with the presence of interstitial lung disease. Diagnosis is made by identifying myositis-specific antibodies directed against aminoacyl tRNA synthetase, and ...
Matthew Wells +10 more
doaj +1 more source
Respiratory Research, 2023 Introduction Interstitial lung disease (ILD) may be difficult to distinguish from other respiratory diseases due to overlapping clinical presentation. Recognition of ILD is often late, causing delay which has been associated with worse clinical outcome ...
Iris G. van der Sar +6 more
doaj +1 more source
Interstitial lung disease [PDF]
European Respiratory Review, 2014 Interstitial lung diseases are a group of diffuse parenchymal lung disorders associated with substantial morbidity and mortality. Knowledge achieved in recent years has resulted in the publication of the new classification of idiopathic interstitial pneumonias, according to which there are three groups: major, rare and unclassified.
Antoniou, Katerina M. +5 more
openaire +4 more sources
Predictors and changes of physical activity in idiopathic pulmonary fibrosis
BMC Pulmonary Medicine, 2022 Background Different clinical predictors of physical activity (PA) have been described in idiopathic pulmonary fibrosis (IPF), but studies are lacking evaluating the potential role of muscle strength and anxiety and depression symptoms in PA limitation ...
Diana Badenes-Bonet +15 more
doaj +1 more source
The Genetics of Interstitial Lung Diseases [PDF]
European Respiratory Review, 2019 Interstitial lung diseases (ILDs) are a set of heterogeneous lung diseases characterised by inflammation and, in some cases, fibrosis. These lung conditions lead to dyspnoea, cough, abnormalities in gas exchange, restrictive physiology (characterised by decreased lung volumes), hypoxaemia and, if progressive, respiratory failure.
Raphael Borie +7 more
openaire +3 more sources
Interstitial Lung Disease in the Elderly [PDF]
Chest, 2017 Despite the relationship between idiopathic pulmonary fibrosis (IPF) and advancing age, little is known about the epidemiology of interstitial lung disease (ILD) in the elderly. We describe the diagnoses, clinical characteristics, and outcomes of patients who were elderly at the time of ILD diagnosis.Among subjects from a prospective cohort study of ...
Patterson, Karen C +11 more
openaire +2 more sources